Understanding this mechanism would not only support the use of ECRG4 expression as a marker for infection and chronic wound risk in T2DM patients, but also provide a target for restoring ECRG4 expression and, thus, restoring neutrophil responses to decrease these risks. Here, ECRG4 is linked to type 2 diabetes mellitus.